CD4+T、CD8+T淋巴细胞在新型冠状病毒肺炎中的研究进展-《天津医科大学学报》

参考文献/References:

[1] 蒋奕，胡腾，司果，等. 新型冠状病毒感染者T淋巴细胞亚群的改变及动态观察[J]. 实用医院临床杂志，2020，17（4）：35
[2] 陈婉玲，王伟峰，李文涛，等. COVID-19患者外周血T淋巴细胞计数动态变化研究[J]. 中华微生物学和免疫学杂志，2020，40（7）：495
[3] RONIT A， BERG R， BAY J T， et al. Compartmental immunophenotyping in COVID-19 ARDS：a case series[J]. J Allergy Clin Immunol， 2021，1 47（1）：81
[4] SARIS A， REIJNDERS T D， NOSSENT E J， et al. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19[J]. Thorax， 2021.0：1-10.thoraxjnl
[5] LI M， GUO W， DONG Y， et al. Elevated exhaustion levels of NK and CD8（+） T cells as indicators for progression and prognosis of COVID-19 disease[J]. Front Immunol， 2020，11：580237
[6] SHI X P， QIN L J， YANG L， et al. Value of interleukin-6 and CD4+ T-lymphocytopenia in assessing the severity and prognosis of coronavirus disease 2019[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue， 2020， 32（10）：1165
[7] CALVET J， GRATAC?譫S J，AMENGUAL M J，et al. CD4 and CD8 lymphocyte counts as surrogate early markers for progression in SARS-CoV-2 pneumonia：a prospective study[J]. Viruses，2020， 12（11）：1277
[8] LIN Y，BEI C，YI L，et al. Dynamics of NK，CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19[J]. J Cell Mol Med，2020，24（24）：14270
[9] GAO M L， LIU Y L， GUO M Q， et al. Regulatory CD4+ and CD8+ T cells are negatively correlated with CD4+ /CD8+ T cell ratios in patients acutely infected with SARS-CoV-2[J]. J Leukoc Biol，2021，109（1）：91
[10] HUANG Z X， LI W L， LU Y，et al. Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection[J]. J Affect Disord， 2020， 277：375
[11] HORKOVA V， DROBEK A， MUELLER D， et al. Dynamics of the coreceptor-LCK interactions during T cell development shape the self-reactivity of peripheral CD4 and CD8 T cells[J]. Cell Rep，2020， 30（5）：1504
[12] GANJI A，FARAHANI I，KHANSARINEJAD B，et al. Increased expression of CD8 marker on T-cells in COVID-19 patients[J]. Blood Cells Mol Dis， 2020， 83：102437
[13] URRA J M，CABRERA C M，PORRAS L， et al. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients[J]. Clin Immunol， 2020，217：108486
[14] WESTMEIER J，PANISKAKI K， KARAK?魻SE Z，et al. Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients[J]. mBio，2020， 11（5）：e02243
[15] 许靖，韩明锋，赵凤德，等. 155例新型冠状病毒肺炎患者的临床表现与血清免疫学特点[J]. 中华医院感染学杂志，2020，30（15）：2261
[16] 许靖，赵凤德，韩明锋，等. 重型/危重型新型冠状病毒肺炎患者的临床特点分析和预警模型构建[J]. 中华危重病急救医学，2020， 32（4）：401
[17] FOUSTERI G， KUKA M. The elusive identity of CXCR5（+） CD8 T cells in viral infection and autoimmunity：ｃytotoxic， regulatory， or helper cells?[J]. Mol Immunol，2020，119：101
[18] XIE M，YUNIS J，YAO Y，et al. High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses[J]. Clin Transl Immunology，2021，10（2）：e1251
[19] GIULIANO B，RUSSO E，GAMBERINI E，et al.Iron metabolism and lymphocyte characterisation during ＣＯＶＩＤ-19 infection in ICU patients：an observational cohort study[J]. World J Emerg Surg，2020，15（1）：41
[20] JIANG M，GUO Y，LUO Q，et al. T-Cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of coronavirus disease 2019[J]. J Infect Dis，2020，222（2）：198
[21] KHAN F，VAN DEN AKKER Ｔ，HUSSEIN S，et al. Activation of cytotoxic T cell population and inversion of CD4：CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection[J]. J Hematop，2020，13（3）：197
[22] SERRANO-VILLAR S，MART■NEZ-SANZ J，RON R，et al. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS：a prospective multicentre cohort study[J].Lancet HIV，2020，7（8）：e565
[23] DENTONE C，VENA A，LOCONTE M，et al. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa，Italy[J].BMC Infect Dis，2021，21（1）：353
[24] XIAO Y，SHI X，SHE Q，et al. Exploration of turn-positive RT-PCR results and factors related to treatment outcome in COVID-19：a retrospective cohort study[J]. Virulence，2020，11（1）：1250
[25] HELLERSTEIN M. What are the roles of antibodies versus a durable，high quality T-cell response in protective immunity against SARS-CoV-2?[J]. Vaccine X，2020，6：100076

相似文献/References:

[1]冯雪,李伯君,赵芳,等.新型冠状病毒肺炎重症患者高氧血症的危害及精准氧气治疗[J].天津医科大学学报,2021,27(04):423.
[2]王钰铭,于静波,曾强,等.天津市航空口岸新型冠状病毒肺炎疫情输入情况的时空特征分析[J].天津医科大学学报,2023,29(01):63.
　WANG Yu-ming,YU Jing-bo,ZENG Qiang,et al.Analysis on spatio-temporal characteristics of imported COVID-19 cases in Tianjin aviation port[J].Journal of Tianjin Medical University,2023,29(06):63.
[3]王艺霖,宜建英,周春雷,等.奥密克戎低流行时期新型冠状病毒肺炎与甲型流感的流行特点分析[J].天津医科大学学报,2024,30(02):162.[doi:10.20135/j.issn.1006-8147.2024.02.0162]
　WANG Yilin,YI Jianying,ZHOU Chunlei,et al.Analysis of epidemic characteristics of COVID-19 and influenza A during the low prevalence period of Omicron[J].Journal of Tianjin Medical University,2024,30(06):162.[doi:10.20135/j.issn.1006-8147.2024.02.0162]

[1]吴荷宁综述,彭民审校.CD4+T、CD8+T淋巴细胞在新型冠状病毒肺炎中的研究进展[J].天津医科大学学报,2021,27(06):658-660,664.

点击复制

CD4+T、CD8+T淋巴细胞在新型冠状病毒肺炎中的研究进展(PDF)

分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

文章信息/Info

参考文献/References:

相似文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics